Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guilingji Capsule for Idiopathic Oligoasthenoteratospermia
ChiCTR2100054837Phase 4Recruiting
- Sponsor
- Eastern Theater General Hospital
- Start
- Jan 2020
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in idiopathic oligoasthenoteratozoospermia (iOAT) comparing Experimental group (Guilingji) with Control group (placebo) (2 arms). Primary endpoint: Total sperm count in forward motion. Started Jan 2020; status: recruiting.
02
Drugs
Guilingji
03
Conditions
idiopathic oligoasthenoteratozoospermia (iOAT)
Beyond the preview
Go deeper on ChiCTR2100054837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054837.